Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk

Dow Jones

2024/12/05

0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

December 05, 2024 01:34 ET (06:34 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2489100122"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489100122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489100122?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-05 14:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489100122","market":"us","top_or_hot":-1,"title":"Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-12-05 14:34</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"萊佛士醫療","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2489100122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489100122","pubTimestamp":1733380440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗"},"translate_title":"莱佛士医疗面临保险业务亏损的盈利打击——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1},"content_text":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 01:34 ET (06:34 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}